Yafei Mi
Linhai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Dihydromyricetin confers protection against myocardial ischemia-reperfusion injury by inhibiting ferroptosis through direct targeting of PPARα.
Journal: Frontiers in pharmacology
Published: January 23, 2026
Modified Anatomical Ablation Strategy for Mitral Isthmus.
Journal: Pacing and clinical electrophysiology : PACE
Published: August 22, 2025
USP14 modulates cell pyroptosis and ameliorates doxorubicin-induced cardiotoxicity by deubiquitinating and stabilizing SIRT3.
Journal: Free radical biology & medicine
Published: September 26, 2024
Ferroptosis and myocardial ischemia-reperfusion: mechanistic insights and new therapeutic perspectives.
Journal: Frontiers in pharmacology
Published: August 19, 2024
Proteomics Analysis of Five Potential Plasma-derived Exosomal Biomarkers for Acute Myocardial Infarction.
Journal: Current medicinal chemistry
Published: August 16, 2024
Corrigendum to "SIRT3 attenuates doxorubicin-induced cardiotoxicity by inhibiting NLRP3 inflammasome via autophagy" [Biochem. Pharmacol. 207 (2023) 115354].
Journal: Biochemical pharmacology
Published: February 22, 2023
SIRT3 attenuates doxorubicin-induced cardiotoxicity by inhibiting NLRP3 inflammasome via autophagy.
Journal: Biochemical pharmacology
Published: September 01, 2022
LCZ696 protects against doxorubicin-induced cardiotoxicity by inhibiting ferroptosis via AKT/SIRT3/SOD2 signaling pathway activation.
Journal: International immunopharmacology
Published: July 01, 2022
Discovery of potential plasma protein biomarkers for acute myocardial infarction via proteomics.
Journal: Journal of thoracic disease
Published: October 28, 2019
rhBMP‑7 suppresses TGF‑β1‑induced endothelial to mesenchymal transition in circulating endothelial cells by regulating Smad5.
Journal: Molecular medicine reports
Published: October 20, 2018
Last Updated: 09/26/2026